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The surface characteristics of an implant that inﬂuence the speed and strength of osseointegration include crystal structure and bioactivity. The
aim of this study was to evaluate the bioactivity of a novel natural hydroxyapatite/zircon (NHA/zircon) nanobiocomposite coating on 316L
stainless steel (SS) dental implants soaking in simulated body ﬂuid. A novel NHA/zircon nanobiocomposite was fabricated with 0 (control),
5, 10, and 15 wt% of zircon in NHA using ball mill for 1 h. The composite mixture was coated on SS implants using a plasma spray method.
Scanning electron microscopy (SEM) was used to evaluate surface morphology, and X-ray diffraction (XRD) was used to analyze phase
composition and crystallinity (Xc). Further, calcium ion release was measured to evaluate the coated nanobiocomposite samples. The prepared
NHA/zircon coating had a nanoscale morphological structure with a mean crystallite size of 30–40 nm in diameter and a bone-like composition,
which is similar to that of the biological apatite of a bone. For the prepared NHA powder, high bioactivity was observed owing to the formation
of apatite crystals on its surface. Both minimum crystallinity (Xc¼41.1%) and maximum bioactivity occurred in the sample containing 10 wt% of
zircon because of minimum Xc and maximum biodegradation of the coating sample.
& 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
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Dental implants have become an established treatment
method since their introduction over 40 years ago. According
to Albrektsson et al., the quality of the implant surface is
a major factor that inﬂuences wound healing at the implanta-
tion site and subsequently affects osseointegration [1]. Surface-
modiﬁed implants have the advantages of (a) providing better
stability between the bone and the implant, established by a/10.1016/j.pnsc.2014.04.001
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nder responsibility of Chinese Materials Research Society.greater contact area, during the healing process, (b) providing a
surface conﬁguration that may retain the blood clot, and (c)
stimulating bone formation and healing process [2].
The quality of the implant surface can be improved with
numerous methods; one of which involves depositing bioactive
materials onto the surface of the dental implant to induce
osteoconductivity. Hydroxyapatite, [Ca10(PO4)6(OH)2: HA], is
a calcium phosphate bioceramic material with a chemical
composition almost identical to that of mineral components
of a bone. HA-coated implants have often been used in load-
bearing applications owing to their capability of bonding
directly to the bone and improving new bone formation
necessary for implant osseointegration [3–6]. Moreover, they
have excellent bioactivity and are osteoconductive allowing
bone cells to grow on their surfaces. Moreover, bioactive
materials, such as HA, can integrate well with living boneElsevier B.V. All rights reserved.
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like apatite layer on their surfaces. HA products are exten-
sively used as implantable ceramics for hard tissue reconstitu-
tion. Despite the advantages of HA, its surface degrades and in
some instances separates; therefore, coatings with bioactive
additives have been increasingly promoted, which also inci-
dentally present better and faster osseointegration. Such
additives can improve ﬁnal coating characteristics such as
bioactivity, thermal stability, and mechanical properties. Dif-
ferent materials have been added to HA to improve the ﬁnal
coating characteristics such as bioactivity [7]. Several studies
have been conducted to evaluate additives such as zirconia
(ZrO2) and ZrO2–Al2O3 in dental implant coatings; therefore,
we tried to evaluate the bioactivity of zircon (ZrSiO4) added to
HA coating, as a new coating, in simulated body ﬂuid (SBF)
solution. This solution has been used in several in vitro studies
to evaluate the changes on the surface of a bioactive glass
ceramic [8]. SBF is an inorganic solution whose composition
is similar to that of human blood plasma without organic
components.
Zircon—the mineral name for naturally occurring zirconium
silicate—is a tetragonal mineral consisting of a silicate of
zirconium. The silicate group of biomaterials have the ability
to release silicate ions at a deﬁnite concentration, which helps
in the growth and differentiation of osteoblasts [9] thus leading
to new bone formation. Therefore, this characteristic of zircon
can be advantageous for surface coating of dental implants.
The plasma spraying technique is the most commonly used
method for the application of HA coatings. It is a thermal
spraying procedure in which powder particles are melted in a
high-temperature plasma ﬂame and propelled toward a sub-
strate material to form a coating. The advantages of this
process include high coating adhesion strength and high
deposition rate, which allow rapid formation of coatings
[10]. The aim of this study is to evaluate the bioactivity and
morphological properties of a novel natural HA/zircon (NHA/
zircon) nanobiocomposite coating on 316L stainless steel (SS)
dental implants submersed in SBF solution.2. Material and methods
2.1. Preparation of samples
This research was an experimental in vitro study. Bovine
bones were boiled for 12 h to remove the attached ﬂesh and
fat. Thereafter, the bones were dried for 2 h at 110 1C to
remove moisture. To prevent blackening with soot during
heating, the bones were cut into small pieces of 10 mm
thickness and heated at 500 1C (bone ash) for 2 h in air toTable 1
Composition of 316L SS materials (wt%).
Element Cr Ni Mo M
Composition of 316L SS 18.00 12.00 2.50 1.
From ASTM 16–18 12–14 2.00 2.allow evaporation of organic substances. The resulting black
bone ash was heated for 3 h at 800 1C. This synthesis is called
thermal decomposition of bone resource to create NHA. In this
work, 316L SS was used as the substrate. The components of
316L SS were examined using elemental analysis, and the
elemental composition is shown in Table 1. Specimens of
dimensions 50 2 mm2 (diameter thickness) were cut
with the CNC wire-cutting EDM Machine (DK7732F, China
suppliers). The samples were polished with a 100–1200 grit
silicon carbide (SiC) paper. To produce a scratch-free surface,
ﬁnal polishing was performed using 1000 grit SiC papers. The
specimens were cleaned with acetone and thoroughly washed
with distilled water. Subsequently, the specimens were surface
treated by grit blasting to obtain the desired surface roughness
for better adhesion of the coating to the substrate. After
the surface treatment process, the specimens were cleaned
with distilled water using an ultrasonic cleaner. NHA/zircon
nanobiocomposite was fabricated with 0 (control), 5, 10, and
15 wt% of zircon in NHA and coated on the surface of the SS
samples using the plasma spray technique. The parameters
used in plasma of powders are shown in Table 2.
2.2. Characterization procedure
Phase structure analysis was performed using X-ray diffrac-
tion (XRD) analysis with a Philips X'Pert Pro MPD diffract-
ometer using Cu Kα radiation (λ1¼0.15418 nm) over a 2θ
range of 20–801. The obtained experimental patterns were
compared with the standard patterns compiled by the Joint
Committee on Powder Diffraction and Standards (JCDPS),
which involved Card no. 09-432 for HA. The crystalline size
and crystallinity (Xc) of the prepared powders were determined
using XRD patterns and the modiﬁed Scherrer equation [11].
In the current study, Xc was measured according to the
procedure described by Karamian et al. [12]. Scanning electron
microscopy (SEM) analysis evaluations were performed using
a Philips XL30 (The Netherlands) to investigate the surface
morphology. The samples were spray coated with Au in high
vacuum at an accelerating voltage of 25 kV. The Ca/P ratio
was determined using energy-dispersive X-ray spectroscopy
(EDX) microanalysis (FEI Quanta 200 ESEM equipped with
an EDX EDS device).
2.3. In vitro bioactivity assessment
NHA/ZrSiO4 nanobiocomposite powders with different
ZrSiO4 contents were prepared and coated using the plasma
spray method. In vitro bioactivity of the nanopowders was
investigated by soaking the samples in SBF solution. The SBFn P C S Si Fe
80 0.04 0.02 0.02 0.15 Balance
00 0.075 0.02 0.03 1.00 Balance
Table 2
Parameters used in plasma of powders.
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Table 3
Comparison of nominal ion concentrations in SBF and human blood plasma.
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Kokubo and Takadama [8]. The coated samples were soaked
in an SBF solution of 7.4 pH at 37 1C for 1, 3, 7, 14, and 21
days at a solid/liquid ratio of 1 mg/mL without refreshing the
soaking medium. Elemental analysis of the prepared SBF is
shown in Table 3. After soaking for the predetermined time
period, the samples were rinsed with deionized water and dried
in an oven at 110 1C for 1 h. The weight loss of the samples
was calculated with the following equation:
Weight loss percentage ðWL%Þ ¼ ðWW0Þ=W0  100;
where W and W0 are the primary and secondary weights,
respectively.
The released calcium ions were measured over 1, 2, and 3
weeks to evaluate the coated nanobiocomposite samples. The
calcium ion concentrations of the solutions were determined
using ICP-OES; an average of 5 measurements was taken for
each sample, and the typical standard deviation was 0.05–
0.2 ppm. To verify the accuracy of the experimental results,
the bioactivity measurements were performed two times.
3. Results
3.1. XRD results analysis
Fig. 1(a) shows the XRD patterns of the sintered NHA 0%
zircon coating. It illustrates that the only existing phase is for
HA. Fig. 1(b) shows the XRD patterns of the coating
containing a mixture of NHA and 10% zircon that is
composited for 1 h. The presence of 10% of zircon did not
create a new phase, which is less than the detection extent of
the XRD technique 0.05. However, the presence of zircon
resulted in a decrease in peak intensity and a slight increase in
peak width of the HA owing to the presence of Si and Zr.Therefore, although the presence of 10 wt% of zircon in NHA
did not create a new phase, it was effective, as discussed.
Moreover, the peaks exhibit a slight shift and a bit decrease of
crystallinity, Xc. These ﬁndings obtained using XRD data of
NHA 10% zircon are compared with those of HA coating.
3.2. SEM evaluation and EDX analysis
SEM observations of the NHA 0% and 10% zircon coatings
after soaking in SBF for 1 and 2 weeks are illustrated in Fig. 2.
In the samples, agglomerated spherical and semi-spherical
nanoparticles of HA crystals having different dimensions were
found. These microphotographs have been taken from different
locations on the NHA/zircon samples. The NHA 0% zircon
sample has higher density than the NHA 10% zircon. These
micrographs show the formation and growth of apatite crystals
on the surface of the NHA 10% coating after soaking in the
SBF solution. The micro-chemical analysis of the NHA 10%
zircon sample was determined using EDX (Fig. 3).
3.3. Bioactivity evaluation of NHA/zircon coating
Bioactivity of the NHA 10% zircon coating was measured
two times to verify the accuracy of the ﬁndings and prevent
bias occurrence. Xc (41.1%) of this sample was the minimum,
and it was equivalent to the maximum crystalline size (32 nm)
(Table 4).
The results indicate the calcium released after 1, 2, and 3
weeks and weight losses after 1, 3, 7, 14, and 21 days of
soaking the samples in the SBF solution (Tables 5 and 6).
Analytical values are based on the mean and standard deviation
(SD) of three replicates. In all the cases, SD was less than 2%.
Tables 5 and 6 summarize the ﬁndings of bioactivity analyses.
Table 5 illustrates that the calcium release increased signiﬁcantly
after 2 weeks and slightly after 3 weeks in the sample containing
10% zircon. After 2 weeks, weight loss was the most for the
NHA 10% zircon sample. Fig. 4(a) indicates that calcium
release increases in the sample containing 10% zircon and is
the highest among all the samples. Fig. 4(b) shows a comparison
of calcium release and pH variation. As the release of calcium
increases after 1 week, pH decreases. Among the samples, the
NHA 10% zircon sample had the most weight losses, as shown
in Table 6.
As can be seen in Fig. 2, the growth of apatite layer for
nanocomposite coatings with different amounts of zircon
differed markedly from another. It is obvious to see that surface
layer grows thicker with increase in zircon amounts. These
bright topographic changes recommend that chemical ingrowths
of calcium phosphate types occurred; in fact, it shows the
bioactive potential of the prepared coatings. Fig. 1(a) shows
SEM photomicrographs of NHA 10% zircon coating sample.
The SEM photomicrograph reveals a relatively uniform dis-
tribution of the zircon nanoparticles in the NHA matrix. Fig. 2
(a)–(d) shows SEM photomicrographs of NHA and NHA 10%
zircon coating samples after 1 and 2 weeks of immersion time in
SBF solution for comparison. It can be seen from Fig. 2(a) that
the corrosion has occurred in NHA coated sample without
Fig. 1. XRD patterns of (a) NHA 0% zircon and (b) NHA 10% zircon coatings on 316L SS. SEM micrographs of (c) NHA 0% zircon and (d) NHA 10% zircon
coatings on 316L SS (see the glassy surface).
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week. Fig. 2(d) shows the formation of white particles in
cauliﬂower shape on the entire surface of the NHA 10% zircon
coating sample and grain boundaries that has been shown by an
arrow. Thus, the addition of zircon nanoparticles to NHA as
reinforcement can accelerate the formation of white particles on
the surface of composite samples.
4. Discussion
In the present study, the bioactivity of NHA/zircon coatings
having different amounts of zircon (0, 5, 10, and 15 wt%)
soaked in SBF solution was evaluated using XRD and SEM
analyses. These coatings were fabricated on 316L SS cores.
316L SS may corrode inside the body under certain circum-
stances in a highly stressed and oxygen-depleted region, such
as contacts under the screws of a bone fracture plate. There-
fore, 316L SS is suitable only in temporary implant devices
such as fracture plates, screws, hip nails, and dental implants.
Surface modiﬁcation methods such as anodization, passivation,
and glow-discharge nitrogen implantation are widely used to
improve corrosion resistance, wear resistance, and adhesion of
316L SS [13]. 316L SS and Ti alloys are useful in dentistry
because of their durability and stability. In this study, the
characteristics of SS were improved and evaluated by adding a
new type of coating (NHA/zircon) to promote coating/sub-
strate interface.Zircon is a tetragonal mineral, consisting of a silicate of
zirconium. Silicate biomaterials have the ability to release
silicate ions at a deﬁnite concentration, which helps in the
growth and differentiation of osteoblasts [14], thus leading to
bone formation. Therefore, in this study, this characteristic of
zircon that can be used for surface coating of dental implants
was investigated.
Tiny agglomerated apatite particles can be formed on the
surface of the sample containing NHA 10% zircon. Shown in
the SEM observations (Fig. 2(b)), the grown layer is some-
times referred to as a bone-like apatite because its XRD pattern
(Fig. 1(b)) is similar to that of a bone apatite with broad peaks
at 2θ angles of HA, which indicates a superﬁne grain of apatite
crystallite.
According to Kokubo et al. [15–17], in vitro immersion of
bioactive materials in SBF produces in vivo surface-structure
changes in materials such as bioactive glass ceramic. In vitro
bioresorbability and bioactivity of NHA depend on its crystal-
lite size. In the current study, Xc was measured according to
the procedure described by Karamian et al. [12]. As can be
observed from the Xc results (Table 4), NHA 10% zircon has
the least Xc and the most amorphous structure. The prepared
NHA/zircon powder showed a high bioactivity similar to that
of a biological apatite. In fact, HA dissolution increases as Xc
decreases (Table 4). Maximum bioactivity occurred in the
sample containing 10% zircon because of higher biodegrada-
tion. Therefore, the increase in concentrations of Ca2þ and
Fig. 2. Micrographs of (a) NHA 0% zircon and (b) NHA 10% zircon coatings after soaking in SBF for 1 week and (c) NHA 0% zircon (spherical particles, ↑) and
(d) NHA 10% zircon (grain boundary, ↑ and cauliﬂower, ↙) coatings after soaking in SBF for 2 weeks.
Element Series [wt. %] [Norm. wt. %] [Norm. wt. %] 
Carbon K-series 3.022725991 4.85890391 12.25858833 
Oxygen K-series 20.56386552 33.05554221 62.60685682 
Silicon K-series 0.563041002 0.905064546 0.976514491 
Calcium K-series 5.628165193 9.047036995 6.840402184 
Zirconium L-series 32.43224074 52.13345234 17.31763817 
 Sum: 62.21003845 100 100 
Fig. 3. (a) EDX spectrum of the NHA 10% zircon sample and (b) microchemical
composition determined using EDX.
Table 4
Values of crystallographic parameters of HA phase in all the samples.
Sample Crystallinity (Xc %) Crystallite size 71 (nm)
NHA 0% zircon 44.8 25.5
NHA 5% zircon 43.2 28
NHA 10% zircon 41.1 32
NHA 15% zircon 42.9 28.2
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3 ions resulted in an increase in local supersaturation,
which is beneﬁcial for the nucleation and growth of new
apatite crystals. Moreover, as more samples were dissolved,
more nucleation sites were created. A higher precipitation ratecan be obtained in samples with higher dissolution [18]. The
dissolution and precipitation behavior of apatites are the
primary factors governing their bioactivity [18]. SEM observa-
tion (Fig. 2(b)) shows an amorphous structure and glassy
surface for the NHA 10% zircon coating, leading to more
biodegradation after soaking for 14 days. This micrograph
shows the formation and growth of apatite crystals on the
surface of NHA 10% zircon coating after soaking in the
SBF solution. In fact, the higher the zircon up to 10 wt%,
the faster the apatite crystals grow, which conﬁrms the above
interpretations.
Fig. 4(a) shows the rate of release of calcium ions with
different amounts of zircon from the NHA into SBF, and the
most bioactivity occurs in the sample containing 10% zircon.
The most weight loss and Ca2þ release in the SBF solution
Table 5
Calcium release of samples in SBF for different soaking times.
Sample Ca2þ release in SBF
after 1 week (ppm)
Ca2þ release in SBF
after 2 weeks (ppm)
Ca2þ release in SBF
after 3 weeks (ppm)
NHA 0% zircon 36 78 82
NHA 5% zircon 40 90 93
NHA 10% zircon 62 115 118
NHA 15% zircon 48 96 98
Table 6
Percent weight loss (WL%) of samples in SBF for different soaking times.
Sample WL% of samples in
SBF after 1 day (mg)
WL% of samples in
SBF after 3 days (mg)
WL% of samples in
SBF after 1 week (mg)
WL% of samples in
SBF after 2 weeks (mg)
WL% of samples in
SBF after 3 weeks (mg)
NHA 0% zircon 0 0.11 0.2 0 0
NHA 5% zircon 0 0.10 0.22 0.06 0.03
NHA 10% zircon 0.11 0.35 0.6 0.15 0.13
NHA 15% zircon 0.02 0.12 0.25 0.12 0.09
Fig. 4. (a) Ca2þ ion concentration of the samples with different percentages of zircon nanobiocomposite and (b) total comparison range of pH and Ca2þ ion
concentration after soaking in SBF solution for 1, 3, 7, 14, and 21 days in all the samples.
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zircon. The bioactivity of the nanobiocomposites improved
with increasing amounts of zircon reinforcement, which
particularly affects biological properties. In fact, the presence
of the silicate phase produces glassy components, leading to an
increase in the adherence of the apatite coating base to the
adjacent SS layer. In addition, increasing zircon in some
amounts may improve the homogeneity of the composite, as
is the case in the NHA 10% zircon sample. However, over
insertion of silicate phase into the composite leads to an
increase in porosity, brittleness, and fracture strength, as in the
NHA 15% zircon sample.
As shown in Table 5, calcium release increases dramatically
from the ﬁrst week to the second week. Although this increase
has not continued into the third week, it was minimal
because after the ﬁrst week, only dissolution occurred in the
samples. However, after the second week and probably in the
third week, dissolution as well as apatite formation occurred
thus leading to the control of weight loss (Table 6) in the
samples.There is a consensus regarding the osteoconductivity [19,20]
and biocompatibility [21,22] of HA. The biocompatibility
[23,24], osteoconductivity, and osseointegrity of zirconia have
been discussed in previous studies [25]. In addition, zircon has
a high biological and surface chemical property. Accordingly,
a combination of these characteristics has been found in the
prepared NHA 10% zircon coating.
To summarize, the proposed novel NHA/zircon coating is
suitable for dental applications because of its good bioactivity.
However, considering the novelty of the NHA/zircon coating
and all the limitations of the current work, more research is
needed to validate the present study. Further, the NHA/zircon
coating can be evaluated in future studies by applying on
titanium implants because of the common use of these
implants in dentistry today.
5. Conclusions
HA biodegradation and bioactivity increased in the sample
containing 10% zircon. Moreover, maximum number of Ca2þ
E. Karamian et al. / Progress in Natural Science: Materials International 24 (2014) 150–156156ions was also released in this sample. The presence of chloride ions
in the SBF (153 ppm) induces an increase in HA dissolution.
The presence of zircon decreased NHA powder agglomera-
tion. Zircon in combination with HA can improve osseointe-
gration of an implant. HA/zircon nanobiocomposite implant
coating possesses good bioactivity and is suitable for hard
tissue formation.
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